Here you will find our non-confidential licensing portfolio.
We build up our portfolio by aligning our scientific knowledge and industry needs with a market-driven focus.
For additional information on each project, please contact us at email@example.com
Angiogenic microparticles for wound healing. Addressed to the elderly and diabetic wound care markets.
Post- surgery monitoring
Minimally invasive microsensors for ischemia monitoring. Addressed to the ischemia control in free flaps post-surgery and in the compartment syndrome.
New antimicrobial compounds for multiresistant biofilm resistant bacteria infections.
Novel target and inhibitory compounds for the treatment of pancreatic cancer. Potential use in other solid tumors.
Specialized microrobots for water remediation. Water pollutant remediation and high valued metals rescue.
- PHOTOTREXATE (PHX)
Light-regulated lead compound for the treatment of psoriasis and other skin diseases.
BiofilmChip allow the growth and quantification of bacterial biofilms to determine the best therapeutic intervention for a specific patient.